GWSG
RARE icon

GPS Wealth Strategies Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

GPS Wealth Strategies Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$3.01K – 1337
2025
Q3 		$3.01K Hold
100
– – ﹤0.01% 1364
2025
Q2 		$3.64K Hold
100
– – ﹤0.01% 1268
2025
Q1 		$3.62K Hold
100
– – ﹤0.01% 1224
2024
Q4 		$4.21K Hold
100
– – ﹤0.01% 1125
2024
Q3 		$5.55K Hold
100
– – ﹤0.01% 1080
2024
Q2 		$4.11K Hold
100
– – ﹤0.01% 1100
2024
Q1 		$4.67K Hold
100
– – ﹤0.01% 1011
2023
Q4 		$4.78K Hold
100
– – ﹤0.01% 989
2023
Q3 		$3.56K Hold
100
– – ﹤0.01% 1033
2023
Q2 		$4.61K Hold
100
– – ﹤0.01% 1002
2023
Q1 		$4.01K Buy
+100
New +$4.29K ﹤0.01% 1015
2022
Q4 		– Sell
-100
Closed -$4K – 860
2022
Q3 		$4K Hold
100
– – ﹤0.01% 947
2022
Q2 		$6K Hold
100
– – ﹤0.01% 857
2022
Q1 		$7K Hold
100
– – ﹤0.01% 799
2021
Q4 		$8K Hold
100
– – ﹤0.01% 782
2021
Q3 		$9K Hold
100
– – ﹤0.01% 744
2021
Q2 		$10K Hold
100
– – ﹤0.01% 733
2021
Q1 		$11K Buy
+100
New +$13.6K ﹤0.01% 659

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GPS Wealth Strategies Group's RARE Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2025, closing a stake of 100 shares — an estimated $3.01K sold.

GPS Wealth Strategies Group first reported a position in RARE in Q1 2021 and held it in 18 quarters. The position peaked at $11K in Q1 2021. 287 funds tracked by Wall St. Rank hold RARE as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Ultragenyx Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 100 Ultragenyx Pharmaceutical shares in Q4 2025, an estimated $3.01K.
  • GPS Wealth Strategies Group first reported a position in Ultragenyx Pharmaceutical in Q1 2021 and held it in 18 quarters.
  • GPS Wealth Strategies Group's Ultragenyx Pharmaceutical position peaked at $11K in Q1 2021.
  • 287 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.